Richard A. Meier - 06 May 2021 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role: Director
Signature: /s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol: BMRN
Transactions as of: 06 May 2021
Net transactions value: +$105
Form type: 4
Filing time: 07 May 2021, 19:48:28 UTC
Next filing: 27 May 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BMRN	Common Stock	Options Exercise	$397,350	+15,000	+18%	$26.49	99,340	06 May 2021	Direct
transaction	BMRN	Common Stock	Sale	$397,245	-5,068	-5.1%	$78.38	94,272	06 May 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BMRN	Stock Option (Right to buy Common Stock)	Options Exercise	$0	-15,000	-100%	$0.000000^*	0	06 May 2021	Common Stock	15,000	$26.49	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price in column 4 is the weighted average price. The price actually received ranged from $78.38 to $78.405. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
F2	Reflects the number of options outstanding after the transactions from this specific stock option grant.